News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-13 5:0:46 am Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 GlobeNewsWire
2024-01-08 4:59:0 am Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position GlobeNewswire
2024-01-02 5:35:0 am Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients GlobeNewswire
2023-12-28 2:0:0 pm Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023 GlobeNewswire
2023-12-19 2:19:0 pm Pasithea Therapeutics Announces Results from 2023 Annual Meeting GlobeNewswire
2023-12-11 5:1:0 am Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models GlobeNewswire
2023-11-29 1:27:0 pm Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders GlobeNewswire
2023-11-29 4:59:0 am Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information